Blacklist of bribes paid by health and Family Planning Commission and drug enterprises: 5 years, 2 bad records, 2 years out

Source: on December 31, 2013, following the "nine prohibitions", the national health and Family Planning Commission launched a new attack on the unhealthy trend in the field of medicine purchase and sale The regulations on the establishment of bad records of commercial bribery in the field of pharmaceutical purchase and sale (hereinafter referred to as the regulations) was officially issued a few days ago According to the regulations, all provincial health and family planning administrative departments shall formulate measures for the implementation of the bad records of commercial bribery in the field of medicine purchase and sale, establish the bad records of commercial bribery, and timely publish the bad records of commercial bribery on their government websites It is required by the regulations that for the pharmaceutical production and operation enterprises and their agents once listed in the bad records of local commercial bribery, the public medical institutions or medical and health institutions receiving financial funds in the provincial region shall not purchase their medicines, medical equipment and medical consumables within two years after the list of bad records is published, and the public medical institutions or medical and health institutions receiving financial funds in other provincial regions shall not purchase their medicines, medical equipment and medical consumables Within two years, the student organization shall reduce the scores of the enterprise's products when bidding and purchasing For those listed in the bad records of commercial bribery twice or more within five years, all public medical institutions or medical and health institutions receiving financial funds shall not purchase their drugs, medical equipment and medical consumables within two years It is also proposed in the provisions that any unit or individual who discovers that the staff of a medical and health institution solicits or receives property or property interests from a pharmaceutical production and operation enterprise or its agent shall have the right to report to the relevant departments After receiving the report, the relevant departments shall, in accordance with their duties, promptly investigate and verify it The existing mechanism needs to be sorted out according to the statement of the health and Family Planning Commission, and the regulations will be implemented from March 1, 2014 The purpose of this policy is to "regulate the purchase of drugs, medical equipment, medical consumables and other behaviors of medical and health institutions, stop illegal trading activities, and combat commercial bribery" In an interview with reporters yesterday, Yu Mingde, President of the China Pharmaceutical Enterprise Management Association, said that there is a certain relationship between the problem of medical commercial bribery and some mechanisms of the pharmaceutical industry, which need to be further straightened out "If the hospital compensation system is not in place, the hospital cannot maintain its operation This makes some hospitals pursue the maximum income In the current social division of labor, doctors take a lot of responsibility, but the income of this group is still low compared with their pay In addition, some doctors have the ability to do more medical services, but the current implementation effect of multi-point practice of doctors is still poor " That's what Yu Mingde said.